<?xml version="1.0" encoding="UTF-8"?>
<p>The impact of vaccines on the inequity of those living in poverty is marked. A study of over 16,000 children during the phased introduction of the measles vaccine in Bangladesh in 1982, demonstrated improved health outcome equity when measured by under-5 mortality (
 <xref rid="B11" ref-type="bibr">Bishai et al., 2003</xref>). Further, modeling of the impact of the rotavirus vaccine in India across social strata, which are closely aligned to wealth, suggested that the vaccine program would provide the poor with both health and financial benefits (
 <xref rid="B116" ref-type="bibr">Verguet et al., 2013</xref>). Including such equity impact in the health economic modeling of vaccines would allow policy decisions to be targeted to the most vulnerable in society (
 <xref rid="B96" ref-type="bibr">Riumallo-Herl et al., 2018</xref>). Additional cost-effective benefits observed after the implementation of combined public health initiatives (
 <xref rid="B27" ref-type="bibr">Deogaonkar et al., 2012</xref>; 
 <xref rid="B37" ref-type="bibr">Gessner et al., 2017</xref>) include provision of vaccines, facilitation of healthcare, reduction of indoor air pollution and improvement of nutrition to prevent childhood pneumonia (
 <xref rid="B75" ref-type="bibr">Niessen et al., 2009</xref>).
</p>
